Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication

Neural Plasticity

Volumn 2013, Issue , 2013, Pages

  Pilar Cuéllar, Fuencisla ^a,b   Vidal, Rebeca ^a,b   Díaz, Alvaro ^a,b   Castro, Elena ^a,b   Dos Anjos, Severiano ^a,c   Pascual Brazo, Jesús ^a,b,d   Linge, Raquel ^a,b   Vargas, Veronica ^a,b   Blanco, Helena ^a   Martínez Villayandre, Beatriz ^a   Pazos, Ángel ^a,b   Valdizán, Elsa M ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Stem Center   (Spain)

^d KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 6 METHOXY 3ALPHA TROPANYL ESTER; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; ANTIDEPRESSANT AGENT; BETA CATENIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; DESIPRAMINE; FLUOXETINE; KETANSERIN; LU AA 21004; MONOAMINE OXIDASE INHIBITOR; NEUROTROPHIC FACTOR; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN; VENLAFAXINE; VORTIOXETINE; WNT PROTEIN;

ANTIDEPRESSANT ACTIVITY; CELL PROLIFERATION; DEPRESSION; HIPPOCAMPUS; HUMAN; INTRACELLULAR SIGNALING; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; REVIEW; DEPRESSIVE DISORDER; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; DRUG EFFECT;

ANTIDEPRESSIVE AGENTS; CELL PROLIFERATION; DEPRESSIVE DISORDER; HIPPOCAMPUS; HUMANS; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION;

EID: 84880154661     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2013/537265     Document Type: Review

References (264)

1. WHO, The world health report. 2001
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994 APA Press
3. Bylsma L. M., Morris B. H., Rottenberg J., A meta-analysis of emotional reactivity in major depressive disorder. Clinical Psychology Review 2008 28 4 676 691 2-s2.0-40649089668 10.1016/j.cpr.2007.10.001 (Pubitemid 351374605)
4. Treadway M. T., Zald D. H., Reconsidering anhedonia in depression: lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews 2011 35 3 537 555 2-s2.0-78649904946 10.1016/j.neubiorev.2010.06.006
5. Koenigs M., Grafman J., The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behavioural Brain Research 2009 201 2 239 243 2-s2.0-67349122031 10.1016/j.bbr.2009.03.004
6. Price J. L., Drevets W. C., Neurocircuitry of mood disorders. Neuropsychopharmacology 2010 35 1 192 216 2-s2.0-72049127264 10.1038/npp.2009.104
7. Price J. L., Drevets W. C., Neural circuits underlying the pathophysiology of mood disorders. Trends in Cognitive Sciences 2012 16 61 71
8. Pascual-Brazo J., Castro E., Diaz A., Valdizán E. M., Pilar-Cuéllar F., Vidal R., Treceño B., Pazos A., Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT(4) receptor agonist RS67333. International Journal of Neuropsychopharmacology 2012 15 5 631 643 10.1017/S1461145711000782
9. Xia L., Delomenie C., David I., Rainer Q., Marouard M., Delacroix H., David D. J., Gardier A. M., Guilloux J. P., Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT(1)A and 5-HT(1)B receptors disruption in mice. Neuroscience Letters 2012 521 1 20 25 10.1016/j.neulet.2012.05.046
10. Mostany R., Valdizán E. M., Pazos A., A role for nuclear β -catenin in SNRI antidepressant-induced hippocampal cell proliferation. Neuropharmacology 2008 55 1 18 26 2-s2.0-45849085732 10.1016/j.neuropharm.2008. 04.012
11. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., Popoli M., Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacological Reviews 2006 58 1 115 134 2-s2.0-33644596087 10.1124/pr.58.1.7
12. Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J., Monteggia L. M., Neurobiology of depression. Neuron 2002 34 1 13 25 2-s2.0-0037187646 10.1016/S0896-6273(02)00653-0 (Pubitemid 34270695)
13. Berton O., Nestler E. J., New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews Neuroscience 2006 7 2 137 151 2-s2.0-31444441701 10.1038/nrn1846 (Pubitemid 43151600)
14. Caspi A., Sugden K., Moffitt T. E., Taylor A., Craig I. W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003 301 5631 386 389 2-s2.0-0037624040 10.1126/science.1083968 (Pubitemid 36877077)
15. Ban T. A., Pharmacotherapy of depression: a historical analysis. Journal of Neural Transmission 2001 108 6 707 716 2-s2.0-0034922165 10.1007/ s007020170047 (Pubitemid 32662414)
16. Schildkraut J. J., The catecholamine hypothesis of affective disorders: a review of supporting evidence. The American Journal of Psychiatry 1965 122 5 509 522 2-s2.0-0000264756
17. Ruhé H. G., Mason N. S., Schene A. H., Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry 2007 12 4 331 359 2-s2.0-33947653784 10.1038/sj.mp.4001949 (Pubitemid 46496835)
18. Duman R. S., Heninger G. R., Nestler E. J., A molecular and cellular theory of depression. Archives of General Psychiatry 1997 54 7 597 606 2-s2.0-0030851206 (Pubitemid 27306570)
19. Duman R. S., Malberg J., Thome J., Neural plasticity to stress and antidepressant treatment. Biological Psychiatry 1999 46 9 1181 1191 2-s2.0-0033232499 10.1016/S0006-3223(99)00177-8 (Pubitemid 30114436)
20. Czéh B., Michaelis T., Watanabe T., Frahm J., De Biurrun G., Van Kampen M., Bartolomucci A., Fuchs E., Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12796 12801 2-s2.0-0035940496 10.1073/pnas.211427898 (Pubitemid 33020024)
21. Malberg J. E., Duman R. S., Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003 28 9 1562 1571 2-s2.0-0141669079 10.1038/sj.npp.1300234 (Pubitemid 41070856)
22. Warner-Schmidt J. L., Duman R. S., Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006 16 3 239 249 2-s2.0-33645109592 10.1002/hipo.20156
23. Sahay A., Hen R., Adult hippocampal neurogenesis in depression. Nature Neuroscience 2007 10 9 1110 1115 2-s2.0-34548348778 10.1038/nn1969 (Pubitemid 47339960)
24. Sahay A., Drew M. R., Hen R., Dentate gyrus neurogenesis and depression. Progress in Brain Research 2007 163 697 722 2-s2.0-34548244063 10.1016/S0079-6123(07)63038-6 (Pubitemid 47321459)
25. Duman C. H., Schlesinger L., Russell D. S., Duman R. S., Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Research C 2008 1199 148 158 2-s2.0-40049093899 10.1016/j.brainres.2007. 12.047
26. Madsen T. M., Newton S. S., Eaton M. E., Russell D. S., Duman R. S., Chronic electroconvulsive seizure up-regulates β -catenin expression in rat hippocampus: role in adult neurogenesis. Biological Psychiatry 2003 54 10 1006 1014 2-s2.0-0242391951 10.1016/S0006-3223(03)00700-5 (Pubitemid 37415035)
27. Li N., Lee B., Liu R. J., Banasr M., Dwyer J. M., Iwata M., Li X. Y., Aghajanian G., Duman R. S., mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010 329 5994 959 964 2-s2.0-77955909841 10.1126/science.1190287
28. Lee H. J., Kim J. W., Yim S. V., Kim M. J., Kim S. A., Kim Y. J., Kim C. J., Chung J. H., Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Molecular Psychiatry 2001 6 6 725 728 2-s2.0-0034751679 10.1038/sj.mp.4000947 (Pubitemid 33020593)
29. Heine V. M., Maslam S., Zareno J., Joëls M., Lucassen P. J., Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. European Journal of Neuroscience 2004 19 1 131 144 2-s2.0-1642499190 10.1046/j.1460-9568.2003.03100.x (Pubitemid 38122079)
30. Jaako-Movits K., Zharkovsky T., Pedersen M., Zharkovsky A., Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration. Cellular and Molecular Neurobiology 2006 26 7-8 1559 1570 2-s2.0-33845523848 10.1007/s10571-006-9090-4 (Pubitemid 44924066)
31. Xu Y., Barish P. A., Pan J., Ogle W. O., O'Donnell J. M., Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis. Methods in Molecular Biology 2012 829 103 124
32. Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G., Vannier M. W., Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America 1996 93 9 3908 3913 2-s2.0-0029862949 10.1073/pnas.93.9.3908 (Pubitemid 26144221)
33. Bremner J. D., Narayan M., Anderson E. R., Staib L. H., Miller H. L., Charney D. S., Hippocampal volume reduction in major depression. American Journal of Psychiatry 2000 157 1 115 117 2-s2.0-0033970356 (Pubitemid 30027430)
34. Stockmeier C. A., Mahajan G. J., Konick L. C., Overholser J. C., Jurjus G. J., Meltzer H. Y., Uylings H. B. M., Friedman L., Rajkowska G., Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry 2004 56 9 640 650 2-s2.0-7444239843 10.1016/j.biopsych.2004.08.022 (Pubitemid 39446845)
35. Beauquis J., Roig P., Homo-Delarche F., De Nicola A., Saravia F., Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. European Journal of Neuroscience 2006 23 6 1539 1546 2-s2.0-33645105249 10.1111/j.1460-9568.2006. 04691.x
36. Czéh B., Müller-Keuker J. I. H., Rygula R., Abumaria N., Hiemke C., Domenici E., Fuchs E., Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 2007 32 7 1490 1503 2-s2.0-34250357250 10.1038/sj.npp.1301275 (Pubitemid 46920152)
37. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T., Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neuroscience Research 2008 60 2 184 191 2-s2.0-38649119109 10.1016/j.neures.2007.10.010
38. Tordera R. M., Garcia-García A. L., Elizalde N., Segura V., Aso E., Venzala E., Ramírez M. J., Del Rio J., Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex. European Neuropsychopharmacology 2011 21 1 23 32 2-s2.0-78650678943 10.1016/j.euroneuro.2010.06.016
39. Blugeot A., Rivat C., Bouvier E., Molet J., Mouchard A., Zeau B., Bernard C., Benoliel J. J., Becker C., Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. Journal of Neuroscience 2011 31 36 12889 12899
40. Kodama M., Fujioka T., Duman R. S., Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biological Psychiatry 2004 56 8 570 580 2-s2.0-5044229846 10.1016/j.biopsych.2004.07.008 (Pubitemid 39336404)
41. Castro J. E., Varea E., Márquez C., Cordero M. I., Poirier G., Sandi C., Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat. PLoS ONE 2010 5 1 2-s2.0-77649153326 10.1371/journal.pone.0008618 e8618
42. Diamond D. M., Campbell A., Park C. R., Vouimba R. M., Preclinical research on stress, memory, and the brain in the development of pharmacotherapy for depression. European Neuropsychopharmacology 2004 14 supplement 5 S491 S495 2-s2.0-8844255504 10.1016/j.euroneuro.2004.09.003 (Pubitemid 39531610)
43. Thome J., Sakai N., Shin K. H., Steffen C., Zhang Y. J., Impey S., Storm D., Duman R. S., cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. Journal of Neuroscience 2000 20 11 4030 4036 2-s2.0-0034213455 (Pubitemid 30365673)
44. Chen A. C. H., Shirayama Y., Shin K. H., Neve R. L., Duman R. S., Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biological Psychiatry 2001 49 9 753 762 2-s2.0-0035338399 10.1016/S0006-3223(00)01114-8 (Pubitemid 32452296)
45. Penzes P., Cahill M. E., Jones K. A., Vanleeuwen J. E., Woolfrey K. M., Dendritic spine pathology in neuropsychiatric disorders. Nature Neuroscience 2011 14 3 285 293 2-s2.0-79951960867 10.1038/nn.2741
46. Cook S. C., Wellman C. L., Chronic stress alters dendritic morphology in rat medial prefrontal cortex. Journal of Neurobiology 2004 60 2 236 248 2-s2.0-3442877504 10.1002/neu.20025 (Pubitemid 39006996)
47. Radley J. J., Sisti H. M., Hao J., Rocher A. B., McCall T., Hof P. R., McEwen B. S., Morrison J. H., Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004 125 1 1 6 2-s2.0-1642421311 10.1016/j.neuroscience.2004.01.006 (Pubitemid 38402153)
48. Öngür D., Drevets W. C., Price J. L., Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 1998 95 22 13290 13295 2-s2.0-0032573166 10.1073/pnas.95.22.13290 (Pubitemid 28509564)
49. Bowley M. P., Drevets W. C., Öngür D., Price J. L., Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 2002 52 5 404 412 2-s2.0-0036753235 10.1016/S0006-3223(02)01404-X (Pubitemid 35266731)
50. Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S. D., Meltzer H. Y., Overholser J. C., Roth B. L., Stockmeier C. A., Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 1999 45 9 1085 1098 2-s2.0-0033135401 10.1016/S0006- 3223(99)00041-4 (Pubitemid 29236550)
51. Popoli M., Yan Z., McEwen B. S., Sanacora G., The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nature Reviews Neuroscience 2012 13 22 37
52. Cerqueira J. J., Mailliet F., Almeida O. F. X., Jay T. M., Sousa N., The prefrontal cortex as a key target of the maladaptive response to stress. Journal of Neuroscience 2007 27 11 2781 2787 2-s2.0-33947313358 10.1523/JNEUROSCI.4372- 06.2007 (Pubitemid 46438976)
53. Lucassen P. J., Müller M. B., Holsboer F., Bauer J., Holtrop A., Wouda J., Hoogendijk W. J. G., De Kloet E. R., Swaab D. F., Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. American Journal of Pathology 2001 158 2 453 468 2-s2.0-0035135843 (Pubitemid 32158608)
54. Bachis A., Cruz M. I., Nosheny R. L., Mocchetti I., Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neuroscience Letters 2008 442 2 104 108 2-s2.0-48149096538 10.1016/j.neulet.2008.06.081
55. Kosten T. A., Galloway M. P., Duman R. S., Russell D. S., D'Sa C., Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008 33 7 1545 1558 2-s2.0-43649084022 10.1038/sj.npp.1301527 (Pubitemid 351684697)
56. Nibuya M., Morinobu S., Duman R. S., Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995 15 11 7539 7547 2-s2.0-0028815653
57. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., Castrén E., Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 2003 23 1 349 357 2-s2.0-0037218768 (Pubitemid 36050437)
58. Lucassen P. J., Fuchs E., Czéh B., Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biological Psychiatry 2004 55 8 789 796 2-s2.0-1642558899 10.1016/j.biopsych.2003.12.014 (Pubitemid 38429869)
59. Ueda S., Sakakibara S., Yoshimoto K., Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning. Neuroscience 2005 135 2 395 402 2-s2.0-24944474805 10.1016/j.neuroscience.2005.06.065 (Pubitemid 41317378)
60. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 2000 20 24 9104 9110 2-s2.0-0034671366 (Pubitemid 32042912)
61. Sairanen M., Lucas G., Ernfors P., Castrén M., Castrén E., Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience 2005 25 5 1089 1094 2-s2.0-13944257674 10.1523/JNEUROSCI.3741-04.2005 (Pubitemid 40268949)
62. Alonso R., Griebel G., Pavone G., Stemmelin J., Le Fur G., Soubrié P., Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Molecular Psychiatry 2004 9 3 278 286 2-s2.0-1942502215 10.1038/sj.mp.4001464 (Pubitemid 38496719)
63. Lucas G., Du J., Romeas T., Mnie-Filali O., Haddjeri N., Piñeyro G., Debonnel G., Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. PLoS ONE 2010 5 2 2-s2.0-77949523855 10.1371/journal.pone.0009253 e9253
64. Lucas G., Rymar V. V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Piñeyro G., Sadikot A. F., Debonnel G., Serotonin4 (5-HT4) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007 55 5 712 725 2-s2.0-34548246547 10.1016/j.neuron.2007.07.041 (Pubitemid 47334877)
65. Tamburella A., Micale V., Navarria A., Drago F., Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 33 7 1205 1210 2-s2.0-69349087191 10.1016/j.pnpbp.2009.07.001
66. Ferres-Coy A., Pilar-Cuellar F., Vidal R., Paz V., Masana M., Cortés R., Carmona M. C., Campa L., Pazos A., Montefeltro A., Valdizán E. M., Artigas F., Bortolozzi A., RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Translational Psychiatry 2013 3 article e211
67. O'Leary O. F., Zandy S., Dinan T. G., Cryan J. F., Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation. Neuroscience 2013 228 36 46
68. Huo K., Sun Y., Li H., Du X., Wang X., Karlsson N., Zhu C., Blomgren K., Lithium reduced neural progenitor apoptosis in the hippocampus and ameliorated functional deficits after irradiation to the immature mouse brain. Molecular and Cellular Neuroscience 2012 51 32 42
69. Encinas J. M., Vaahtokari A., Enikolopov G., Fluoxetine targets early progenitor cells in the adult brain. Proceedings of the National Academy of Sciences of the United States of America 2006 103 21 8233 8238 2-s2.0-33744487636 10.1073/pnas.0601992103 (Pubitemid 43801081)
70. Segi-Nishida E., Warner-Schmidt J. L., Duman R. S., Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2008 105 32 11352 11357 2-s2.0-49649124146 10.1073/pnas.0710858105
71. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R., Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003 301 5634 805 809 2-s2.0-0042528720 10.1126/science.1083328 (Pubitemid 36962615)
72. Malberg J. E., Schecter L. E., Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Current Pharmaceutical Design 2005 11 2 145 155 2-s2.0-11844288312 10.2174/1381612053382223 (Pubitemid 40089838)
73. Dranovsky A., Hen R., Hippocampal eurogenesis: regulation by stress and antidepressants. Biological Psychiatry 2006 59 12 1136 1143 2-s2.0-33745214865 10.1016/j.biopsych.2006.03.082
74. Banasr M., Hery M., Printemps R., Daszuta A., Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004 29 3 450 460 2-s2.0-1642331289 10.1038/sj.npp.1300320 (Pubitemid 38365922)
75. Wang J. W., David D. J., Monckton J. E., Battaglia F., Hen R., Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. Journal of Neuroscience 2008 28 6 1374 1384 2-s2.0-38949158786 10.1523/JNEUROSCI.3632-07.2008 (Pubitemid 351231535)
76. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., Hen R., Belzung C., Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biological Psychiatry 2008 64 4 293 301 2-s2.0-48049094446 10.1016/j.biopsych.2008.02.022
77. Arnold S. A., Hagg T., Serotonin 1A receptor agonist increases species- and region-selective adult CNS proliferation, but not through CNTF. Neuropharmacology 2012 63 1238 1247
78. Pilar-Cuéllar F., Vidal R., Díaz A., Pathways involved in antidepressant-induced proliferation and synaptic plasticity. Current Pharmaceutical Design. In press
79. Huang G. J., Herbert J., The role of 5-HT1A receptors in the proliferation and survival of progenitor cells in the dentate gyrus of the adult hippocampus and their regulation by corticoids. Neuroscience 2005 135 3 803 813 2-s2.0-33644686822
80. Fricker A. D., Rios C., Devi L. A., Gomes I., Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Molecular Brain Research 2005 138 2 228 235 2-s2.0-23744517134 10.1016/j.molbrainres.2005.04.016 (Pubitemid 41138042)
81. Jha S., Rajendran R., Fernandes K. A., Vaidya V. A., 5-HT2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neuroscience Letters 2008 441 2 210 214 2-s2.0-46749092449 10.1016/j.neulet. 2008.06.028
82. Soumier A., Banasr M., Lortet S., Masmejean F., Bernard N., Kerkerian-Le-Goff L., Gabriel C., Millan M. J., Mocaer E., Daszuta A., Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 2009 34 11 2390 2403 2-s2.0-70349142643 10.1038/npp.2009.72
83. Pilar-Cuellar F., Vidal R., Pazos A., Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, beta-catenin and antidepressant-like effects. British Journal of Pharmacology 2012 165 1046 1057
84. Foley A. G., Hirst W. D., Gallagher H. C., Barry C., Hagan J. J., Upton N., Walsh F. S., Hunter A. J., Regan C. M., The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacology 2008 54 8 1166 1174 2-s2.0-44149105604 10.1016/j.neuropharm.2008.03.012
85. Mnie-Filali O., Faure C., Lambas-Senas L., Mansari M. E., Belblidia H., Gondard E., Etiévant A., Scarna H., Didier A., Berod A., Blier P., Haddjeri N., Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 2011 36 6 1275 1288 2-s2.0-79954597841 10.1038/npp.2011.13
86. Sarkisyan G., Hedlund P. B., The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behavioural Brain Research 2009 202 1 26 31 2-s2.0-67349267339 10.1016/j.bbr.2009.03.011
87. Menninger J. A., Tabakoff B., Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression. Biological Psychiatry 1997 42 1 30 38 2-s2.0-0030739982 10.1016/S0006-3223(96)00245-4 (Pubitemid 27293533)
88. Valdizán E. M., Gutierrez O., Pazos A., Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to β -adrenergic stimulation. Biological Psychiatry 2003 54 12 1457 1464 2-s2.0-0346850967 10.1016/S0006-3223(03)00589-4 (Pubitemid 37522171)
89. Extein I., Tallman J., Smith C. C., Goodwin F. K., Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Research 1979 1 2 191 197 2-s2.0-0018597959 10.1016/0165-1781(79)90061-1 (Pubitemid 10124731)
90. Halper J. P., Brown R. P., Sweeney J. A., Kocsis J. H., Peters A., Mann J. J., Blunted β -adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Isoproterenol dose-response studies. Archives of General Psychiatry 1988 45 3 241 244 2-s2.0-0023931442 (Pubitemid 18081672)
91. Mann J. J., Halper J. P., Wilner P. J., Sweeney J. A., Mieczkowski T. A., Chen J. S., Stokes P. E., Brown R. P., Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode. Biological Psychiatry 1997 42 10 859 870 2-s2.0-0030695927 10.1016/S0006-3223(97)00154-6 (Pubitemid 27486438)
92. Mazzola-Pomietto P., Azorin J. M., Tramoni V., Jeanningros R., Relation between lymphocyte beta-adrenergic responsivity and the severity of depressive disorders. Biological Psychiatry 1994 35 920 925 (Pubitemid 24212217)
93. Pandey G. N., Sudershan P., Davis J. M., Beta adrenergic receptor function in depression and the effect of antidepressant drugs. Acta Pharmacologica et Toxicologica Supplementum 1985 56 1 66 79 2-s2.0-0021964677 (Pubitemid 15136257)
94. Valdizn E. M., Dez-Alarcia R., Gonzlez-Maeso J., Pilar-Cullar F., Garca-Sevilla J. A., Meana J. J., Pazos A., 2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biological Psychiatry 2010 68 9 869 872 2-s2.0-77957919737 10.1016/j.biopsych.2010.07.023
95. Ozawa H., Rasenick M. M., Chronic electroconvulsive treatment augments coupling of the GTP-binding protein G(s) to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. Journal of Neurochemistry 1991 56 1 330 338 2-s2.0-0025965615 10.1111/j.1471-4159.1991.tb02599.x (Pubitemid 21901967)
96. Watts V. J., Neve K. A., Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacology & Therapeutics 2005 106 405 421 (Pubitemid 40726295)
97. Vidal R., Valdizan E. M., Mostany R., Pazos A., Castro E., Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain. Journal of Neurochemistry 2009 110 3 1120 1127 2-s2.0-67650446830 10.1111/j.1471-4159.2009.06210.x
98. Vidal R., Valdizan E. M., Vilaro M. T., Pazos A., Castro E., Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats. British Journal of Pharmacology 2010 161 3 695 706 2-s2.0-77956318009 10.1111/j.1476-5381.2010.00903.x
99. Zhang H. T., Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Current Pharmaceutical Design 2009 15 14 1688 1698 2-s2.0-67650569455 10.2174/138161209788168092
100. Mato S., Vidal R., Castro E., Díaz A., Pazos A., Valdizán E. M., Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms. Molecular Pharmacology 2010 77 3 424 434 2-s2.0-77149179753 10.1124/mol.109.060079
101. Nestler E. J., Terwilliger R. Z., Duman R. S., Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. Journal of Neurochemistry 1989 53 5 1644 1647 2-s2.0-0024465747 (Pubitemid 19267038)
102. Alfonso J., Frick L. R., Silberman D. M., Palumbo M. L., Genaro A. M., Frasch A. C., Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biological Psychiatry 2006 59 3 244 251 2-s2.0-32144437619 10.1016/j.biopsych. 2005.06.036 (Pubitemid 43208971)
103. Morley-Fletcher S., Mairesse J., Soumier A., Banasr M., Fagioli F., Gabriel C., Mocaer E., Daszuta A., McEwen B., Nicoletti F., Maccari S., Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology 2011 217 3 301 313 2-s2.0-79955095048 10.1007/s00213-011-2280-x
104. Dowlatshahi D., MacQueen G. M., Wang J. F., Young L. T., Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998 352 9142 1754 1755 2-s2.0-0032576396 (Pubitemid 28534964)
105. Dowlatshahi D., MacQueen G. M., Wang J. F., Reiach J. S., Young L. T., G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry 1999 73 3 1121 1126 2-s2.0-0032840527 10.1046/j.1471-4159.1999.0731121.x (Pubitemid 29395470)
106. Odagaki Y., García-Sevilla J. A., Huguelet P., La Harpe R., Koyama T., Guimón J., Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Research 2001 898 2 224 231 2-s2.0-0035917794 10.1016/S0006-8993(01)02188-6 (Pubitemid 32299951)
107. Yamada S., Yamamoto M., Ozawa H., Riederer P., Saito T., Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. Journal of Neural Transmission 2003 110 6 671 680 2-s2.0-0037507158 10.1007/s00702-002-0810-8 (Pubitemid 36683520)
108. Laifenfeld D., Karry R., Grauer E., Klein E., Ben-Shachar D., Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity. Neurobiology of Disease 2005 20 2 432 441 2-s2.0-26944460403 10.1016/j.nbd.2005.03.023 (Pubitemid 41476269)
109. Wallace T. L., Stellitano K. E., Neve R. L., Duman R. S., Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biological Psychiatry 2004 56 3 151 160 2-s2.0-3242752726 10.1016/j.biopsych. 2004.04.010 (Pubitemid 38969147)
110. Manier D. H., Shelton R. C., Sulser F., Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P? Journal of Neural Transmission 2002 109 1 91 99 2-s2.0-0036169831 10.1007/s702-002-8239-6 (Pubitemid 34146592)
111. Pliakas A. M., Carlson R. R., Neve R. L., Konradi C., Nestler E. J., Carlezon W. A., Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. Journal of Neuroscience 2001 21 18 7397 7403 2-s2.0-0035884949 (Pubitemid 32846987)
112. Dwivedi Y., Mondal A. C., Rizavi H. S., Faludi G., Palkovits M., Sarosi A., Conley R. R., Pandey G. N., Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Archives of General Psychiatry 2006 63 6 639 648 2-s2.0-33744932983 10.1001/archpsyc.63.6.639 (Pubitemid 43848295)
113. Liu R., Dang W., Jianting M., Su C., Wang H., Chen Y., Tan Q., Citalopram alleviates chronic stress induced depression-like behaviors in rats by activating GSK3 beta signaling in dorsal hippocampus. Brain Research 2012 1467 10 17 10.1016/j.brainres.2012.05.030
114. Chen G., Huang L. D., Jiang Y. M., Manji H. K., The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry 1999 72 3 1327 1330 2-s2.0-0033014180 10.1046/j.1471-4159.2000. 0721327.x (Pubitemid 29085050)
115. Gould T. D., Chen G., Manji H. K., In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 2004 29 1 32 38 2-s2.0-0346688565 10.1038/sj.npp.1300283 (Pubitemid 38068011)
116. Li X., Zhu W., Roh M. S., Friedman A. B., Rosborough K., Jope R. S., In vivo regulation of glycogen synthase kinase-3 β (GSK3 β) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004 29 8 1426 1431 2-s2.0-3242761438 10.1038/sj.npp.1300439 (Pubitemid 38982234)
117. Beaulieu J. M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R., Caron M. G., Role of GSK3 β in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1333 1338 2-s2.0-39549108481 10.1073/pnas.0711496105 (Pubitemid 351397053)
118. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C. G., Eldar-Finkelman H., Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β -catenin in mouse hippocampus. Biological Psychiatry 2004 55 8 781 784 2-s2.0-1842420631 10.1016/j.biopsych.2004.01.008 (Pubitemid 38429867)
119. O'Brien W. T., Harper A. D., Jové F., Woodgett J. R., Maretto S., Piccolo S., Klein P. S., Glycogen synthase kinase-3 β haploinsufficiency mimics the behavioral and molecular effects of lithium. Journal of Neuroscience 2004 24 30 6791 6798 2-s2.0-3342955475 10.1523/JNEUROSCI.4753-03.2004 (Pubitemid 38993901)
120. Latapy C., Rioux V., Guitton M. J., Beaulieu J. M., Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in
121. Polter A., Beurel E., Yang S., Garner R., Song L., Miller C. A., Sweatt J. D., McMahon L., Bartolucci A. A., Li X., Jope R. S., Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 2010 35 8 1761 1774 2-s2.0-77953596703 10.1038/npp.2010.43
122. Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., Smeraldi E., A glycogen synthase kinase 3- β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neuroscience Letters 2004 368 2 123 126 2-s2.0-4444350746 10.1016/j.neulet.2004.06.050 (Pubitemid 39194855)
123. Benedetti F., Dallaspezia S., Lorenzi C., Pirovano A., Radaelli D., Locatelli C., Poletti S., Colombo C., Smeraldi E., Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. Journal of Affective Disorders 2012 136 514 519
124. Karege F., Perroud N., Burkhardt S., Fernandez R., Ballmann E., La Harpe R., Malafosse A., Protein levels of beta-catenin and activation state of glycogen synthase kinase-3beta in major depression. A study with postmortem prefrontal cortex. Journal of Affective Disorders 2012 136 185 188
125. Gould T. D., O'Donnell K. C., Picchini A. M., Dow E. R., Chen G., Manji H. K., Generation and behavioral characterization of β -catenin forebrain-specific conditional knock-out mice. Behavioural Brain Research 2008 189 1 117 125 2-s2.0-40849094032 10.1016/j.bbr.2007.12.028
126. Gould T. D., Einat H., O'Donnell K. C., Picchini A. M., Schloesser R. J., Manji H. K., Β -catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007 32 10 2173 2183 2-s2.0-34548684164 10.1038/sj.npp.1301338 (Pubitemid 47417687)
127. Howell K. R., Kutiyanawalla A., Pillai A., Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex. PLoS ONE 2011 6 5 2-s2.0-79957598135 10.1371/journal.pone.0020198 e20198
128. Sui L., Wang J., Li B. M., Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learning and Memory 2008 15 10 762 776 2-s2.0-53549099115 10.1101/lm.1067808
129. Chandran A., Iyo A. H., Jernigan C. S., Legutko B., Austin M. C., Karolewicz B., Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013 40 240 245
130. Yu J. J., Zhang Y., Wang Y., Wen Z. Y., Liu X. H., Qin J., Yang J. L., Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. Psychopharmacology 2013 225 361 372
131. Mathew S. J., Keegan K., Smith L., Glutamate modulators as novel interventions for mood disorders. Revista Brasileira de Psiquiatria 2005 27 3 243 248 2-s2.0-25144511925 (Pubitemid 41337491)
132. Brezun J. M., Daszuta A., Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 2000 10 37 46 (Pubitemid 30107588)
133. Cowen D. S., Takase L. F., Fornal C. A., Jacobs B. L., Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine. Brain Research C 2008 1228 14 19 2-s2.0-49349096494 10.1016/j.brainres.2008.06.059
134. Marlatt M. W., Lucassen P. J., van Praag H., Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Brain Research C 2010 1341 93 99 2-s2.0-77953094107 10.1016/j.brainres.2010.03.086
135. Hanson N. D., Nemeroff C. B., Owens M. J., Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus. Journal of Pharmacology and Experimental Therapeutics 2011 337 1 180 186 2-s2.0-79953016389 10.1124/jpet.110.175372
136. Radley J. J., Jacobs B. L., 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Research 2002 955 1-2 264 267 2-s2.0-0037110467 10.1016/S0006-8993(02)03477-7 (Pubitemid 35284859)
137. Marek G. J., Carpenter L. L., McDougle C. J., Price L. H., Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 2003 28 2 402 412 2-s2.0-0037311477
138. Pandey D. K., Mahesh R., Kumar A. A., Rao V. S., Arjun M., Rajkumar R., A novel 5-HT(2A) receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants. Pharmacology Biochemistry and Behavior 2010 94 3 363 373 2-s2.0-72149119722 10.1016/j.pbb.2009.09.018
139. Vaidya V. A., Terwilliger R. M. Z., Duman R. S., Role of 5-HT(2a) receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neuroscience Letters 1999 262 1 1 4 2-s2.0-0033604901 10.1016/S0304-3940(99)00006-3 (Pubitemid 29104944)
140. Gulyas A. I., Acsady L., Freund T. F., Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochemistry International 1999 34 359 372 (Pubitemid 29240632)
141. Rosel P., Arranz B., Urretavizcaya M., Oros M., San L., Navarro M. A., Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAmP in brains from depressed violent suicide victims. Neuropsychobiology 2004 49 4 189 195 2-s2.0-2342527059 10.1159/000077365 (Pubitemid 38594570)
142. Wesołowska A., Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data. Pharmacological Reports 2010 62 4 564 577 2-s2.0-77957983253
143. Wesołowska A., Nikiforuk A., Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 2007 52 5 1274 1283 2-s2.0-34047183030 10.1016/j.neuropharm.2007.01.007 (Pubitemid 46527703)
144. Wesołowska A., Nikiforuk A., The selective 5-HT6 receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. European Journal of Pharmacology 2008 582 1-3 88 93 2-s2.0-39149091707 10.1016/j.ejphar.2007.12.013
145. Wesołowska A., Nikiforuk A., Stachowicz K., Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behavioural Pharmacology 2007 18 5-6 439 446 2-s2.0-34548383532 10.1097/FBP.0b013e3282d28f9c (Pubitemid 47356370)
146. Callaghan C. K., Hok V., Della-Chiesa A., Virley D. J., Upton N., O'Mara S. M., Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457. Neuropharmacology 2012 63 890 897
147. Mnie-Filali O., Lambás-Señas L., Zimmer L., Haddjeri N., 5-HT7 receptor antagonists as a new class of antidepressants. Drug News and Perspectives 2007 20 10 613 618 2-s2.0-41149097102 10.1358/dnp.2007.20.10. 1181354 (Pubitemid 351437589)
148. Stahl S. M., The serotonin-7 receptor as a novel therapeutic target. Journal of Clinical Psychiatry 2010 71 11 1414 1415 2-s2.0-78649766286 10.4088/JCP.10bs06601gry
149. Hedlund P. B., Huitron-Resendiz S., Henriksen S. J., Sutcliffe J. G., 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biological Psychiatry 2005 58 10 831 837 2-s2.0-27944496843 10.1016/j.biopsych.2005.05.012 (Pubitemid 41677422)
150. Alvarez E., Perez V., Dragheim M., Loft H., Artigas F., A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. International Journal of Neuropsychopharmacology 2012 15 589 600
151. Calabrese F., Molteni R., Racagni G., Riva M. A., Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009 34 supplement 1 S208 S216 2-s2.0-71249133201 10.1016/j.psyneuen.2009.05.014
152. Taliaz D., Loya A., Gersner R., Haramati S., Chen A., Zangen A., Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. Journal of Neuroscience 2011 31 12 4475 4483 2-s2.0-79953008100 10.1523/JNEUROSCI.5725-10.2011
153. Hashimoto K., Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010 64 4 341 357 2-s2.0-77955078119 10.1111/j.1440-1819.2010. 02113.x
154. Sen S., Duman R., Sanacora G., Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008 64 6 527 532 2-s2.0-49749101642 10.1016/j.biopsych. 2008.05.005
155. Umene-Nakano W., Yoshimura R., Ikenouchi-Sugita A., Hori H., Hayashi K., Ueda N., Nakamura J., Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence. Human Psychopharmacology 2009 24 5 409 413 2-s2.0-70149092155 10.1002/hup.1035
156. Gonul A. S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S., Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 2005 255 6 381 386 2-s2.0-29744449163 10.1007/s00406-005-0578-6 (Pubitemid 43029827)
157. Kim Y. K., Lee H. P., Won S. D., Park E. Y., Lee H. Y., Lee B. H., Lee S. W., Yoon D., Han C., Kim D. J., Choi S. H., Low plasma BDNF is associated with suicidal behavior in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 31 1 78 85 2-s2.0-33845635596 10.1016/j.pnpbp.2006. 06.024 (Pubitemid 44959250)
158. Monteggia L. M., Barrot M., Powell C. M., Berton O., Galanis V., Gemelli T., Meuth S., Nagy A., Greene R. W., Nestler E. J., Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proceedings of the National Academy of Sciences of the United States of America 2004 101 29 10827 10832 2-s2.0-3242666768 10.1073/pnas.0402141101 (Pubitemid 38955827)
159. Chen Z. Y., Jing D., Bath K. G., Ieraci A., Khan T., Siao C. J., Herrera D. G., Toth M., Yang C., McEwen B. S., Hempstead B. L., Lee F. S., Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006 314 5796 140 143 2-s2.0-33749649795 10.1126/science.1129663 (Pubitemid 44547760)
160. Adachi M., Barrot M., Autry A. E., Theobald D., Monteggia L. M., Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biological Psychiatry 2008 63 7 642 649 2-s2.0-40149097433 10.1016/j.biopsych.2007.09.019 (Pubitemid 351329281)
161. Siuciak J. A., Lewis D. R., Wiegand S. J., Lindsay R. M., Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology Biochemistry and Behavior 1997 56 1 131 137 2-s2.0-0031031001 10.1016/S0091-3057(96)00169-4 (Pubitemid 27016116)
162. Hoshaw B. A., Malberg J. E., Lucki I., Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research 2005 1037 1-2 204 208 2-s2.0-14944358464 10.1016/j.brainres.2005.01.007 (Pubitemid 40362398)
163. Shirayama Y., Chen A. C. H., Nakagawa S., Russell D. S., Duman R. S., Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 2002 22 8 3251 3261 2-s2.0-0037092425 (Pubitemid 35379212)
164. Ye Y., Wang G., Wang H., Wang X., Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression. Neuroscience Letters 2011 503 15 19
165. Schmidt H. D., Duman R. S., Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010 35 12 2378 2391 2-s2.0-77958021917 10.1038/npp.2010.114
166. Tadić A., Wagner S., Schlicht K. F., Peetz D., Borysenko L., Dreimüller N., Hiemke C., Lieb K., The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 2 415 420 2-s2.0-79952901686 10.1016/j.pnpbp.2010.08.011
167. Duman R. S., Monteggia L. M., A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006 59 12 1116 1127 2-s2.0-33745208951 10.1016/j.biopsych.2006.02.013
168. Vaidya V. A., Marek G. J., Aghajanian G. K., Duman R. S., 5-HT(2A) receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. Journal of Neuroscience 1997 17 8 2785 2795 2-s2.0-0030611192 (Pubitemid 27155012)
169. Choi S. H., Li Y., Parada L. F., Sisodia S. S., Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Molecular Neurodegeneration 2009 4 1, article 52 2-s2.0-74849094086 10.1186/1750-1326-4-52
170. Son H., Banasr M., Choi M., Chae S. Y., Licznerski P., Lee B., Voleti B., Li N., Lepack A., Fournier N. M., Lee K. R., Lee I. Y., Kim J., Kim J. H., Kim Y. H., Jung S. J., Duman R. S., Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proceedings of the National Academy of Sciences of the United States of America 2012 109 28 11378 11383
171. Alme M. N., Wibrand K., Dagestad G., Bramham C. R., Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plasticity 2007 2007 9 2-s2.0-36849007594 10.1155/2007/26496 26496 (Pubitemid 350226804)
172. Egan M. F., Kojima M., Callicott J. H., Goldberg T. E., Kolachana B. S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D. R., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003 112 2 257 269 2-s2.0-0037462449 10.1016/S0092-8674(03)00035-7 (Pubitemid 36144114)
173. Sen S., Nesse R. M., Stoltenberg S. F., Li S., Gleiberman L., Chakravarti A., Weder A. B., Burmeister M., A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003 28 2 397 401 2-s2.0-0037310231
174. Verhagen M., Van Der Meij A., Van Deurzen P. M., Janzing J., Arias-Vásquez A., Buitelaar J., Franke B., Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 2010 15 3 260 271 2-s2.0-77249091890 10.1038/mp.2008.109
175. Yu H., Wang D. D., Wang Y., Liu T., Lee F. S., Chen Z. Y., Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. Journal of Neuroscience 2012 32 12 4092 4101
176. Kocabas N. A., Antonijevic I., Faghel C., Forray C., Kasper S., Lecrubier Y., Linotte S., Massat I., Mendlewicz J., Noro M., Montgomery S., Oswald P., Snyder L., Zohar J., Souery D., Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. International Clinical Psychopharmacology 2011 26 1 10
177. Palmer T. D., Willhoite A. R., Gage F. H., Vascular niche for adult hippocampal neurogenesis. Journal of Comparative Neurology 2000 425 479 494
178. Warner-Schmidt J. L., Madsen T. M., Duman R. S., Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. European Journal of Neuroscience 2008 27 6 1485 1493 2-s2.0-40949122425 10.1111/j.1460-9568.2008.06118.x (Pubitemid 351406275)
179. Heine V. M., Zareno J., Maslam S., Joëls M., Lucassen P. J., Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. European Journal of Neuroscience 2005 21 5 1304 1314 2-s2.0-17144409702 10.1111/j.1460-9568.2005. 03951.x (Pubitemid 40516629)
180. Kiuchi T., Lee H., Mikami T., Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice. Neuroscience 2012 207 208 217
181. Newton S. S., Collier E. F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., Duman R. S., Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. Journal of Neuroscience 2003 23 34 10841 10851 2-s2.0-0344629712 (Pubitemid 37499691)
182. Altar C. A., Laeng P., Jurata L. W., Brockman J. A., Lemire A., Bullard J., Bukhman Y. V., Young T. A., Charles V., Palfreyman M. G., Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. Journal of Neuroscience 2004 24 11 2667 2677 2-s2.0-12144290112 10.1523/JNEUROSCI.5377-03.2004 (Pubitemid 38380943)
183. Sun R., Li N., Li T., VEGF regulates antidepressant effects of lamotrigine. European Neuropsychopharmacology 2012 22 424 430
184. Lee J. S., Jang D. J., Lee N., Ko H. G., Kim H., Kim Y. S., Kim B., Son J., Sung H. K., Chung H., Lee M. Y., Woon R. K., Sun W., Zhuo M., Abel T., Kaang B. K., Son H., Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors. Journal of Neuroscience 2009 29 26 8493 8505 2-s2.0-67649921704 10.1523/JNEUROSCI.1321-09.2009
185. Ventriglia M., Zanardini R., Pedrini L., Placentino A., Nielsen M. G., Gennarelli M., Bocchio-Chiavetto L., VEGF serum levels in depressed patients during SSRI antidepressant treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 33 1 146 149 2-s2.0-58149479332 10.1016/j.pnpbp.2008. 11.009
186. Halmai Z., Dome P., Dobos J., Gonda X., Szekely A., Sasvari-Szekely M., Faludi G., Lazary J., Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study. Journal of Affective Disorders 2013 144 269 273
187. Cowen D. S., Serotonin and neuronal growth factors-a convergence of signaling pathways. Journal of Neurochemistry 2007 101 5 1161 1171 2-s2.0-34248196107 10.1111/j.1471-4159.2006.04420.x (Pubitemid 46718809)
188. Peltier J., O'Neill A., Schaffer D. V., PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Developmental Neurobiology 2007 67 10 1348 1361 2-s2.0-34547793039 10.1002/dneu.20506 (Pubitemid 47242761)
189. Gould T. D., Manji H. K., Signaling networks in the pathophysiology and treatment of mood disorders. Journal of Psychosomatic Research 2002 53 687 697 (Pubitemid 36292448)
190. Blendy J. A., The role of CREB in depression and antidepressant treatment. Biological Psychiatry 2006 59 12 1144 1150 2-s2.0-33745222513 10.1016/j.biopsych.2005.11.003
191. Shaywitz A. J., Greenberg M. E., CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annual Review of Biochemistry 1999 68 821 861 2-s2.0-0032852479 10.1146/annurev.biochem.68.1.821 (Pubitemid 29449210)
192. Viola H., Furman M., Izquierdo L. A., Alonso M., Barros D. M., de Souza M. M., Izquierdo I., Medina J. H., Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty. The Journal of Neuroscience 2000 20 23, article RC112 2-s2.0-0034576039
193. Hardingham G. E., Arnold F. J. L., Bading H., Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nature Neuroscience 2001 4 3 261 267 2-s2.0-0035116275 10.1038/85109 (Pubitemid 32194873)
194. Lonze B. E., Ginty D. D., Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002 35 4 605 623 2-s2.0-0037101970 10.1016/S0896-6273(02)00828-0 (Pubitemid 35229980)
195. Carlezon W. A. Jr., Duman R. S., Nestler E. J., The many faces of CREB. Trends in Neurosciences 2005 28 8 436 445 2-s2.0-22144467379 10.1016/j.tins.2005.06.005 (Pubitemid 40982557)
196. Valverde O., Mantamadiotis T., Torrecilla M., Ugedo L., Pineda J., Bleckmann S., Gass P., Kretz O., Mitchell J. M., Schütz G., Maldonado R., Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology 2004 29 6 1122 1133 2-s2.0-2542482845 10.1038/sj.npp.1300416 (Pubitemid 38678642)
197. Nibuya M., Nestler E. J., Duman R. S., Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience 1996 16 7 2365 2372 2-s2.0-0029992189 (Pubitemid 26154346)
198. Perera T. D., Park S., Nemirovskaya Y., Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist 2008 14 4 326 338 2-s2.0-47549107048 10.1177/1073858408317242 (Pubitemid 352010067)
199. Johannessen M., Delghandi M. P., Moens U., What turns CREB on? Cellular Signalling 2004 16 11 1211 1227 2-s2.0-4444280871 10.1016/j.cellsig.2004.05.001 (Pubitemid 39165450)
200. Kim W. Y., Wang X., Wu Y., Doble B. W., Patel S., Woodgett J. R., Snider W. D., GSK-3 is a master regulator of neural progenitor homeostasis. Nature Neuroscience 2009 12 1390 1397
201. Li F., Chong Z. Z., Maiese K., Vital elements of the Wnt-frizzled signaling pathway in the nervous system. Current Neurovascular Research 2005 2 4 331 340 2-s2.0-24744467833 10.2174/156720205774322557 (Pubitemid 41297370)
202. Ciani L., Salinas P. C., WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nature Reviews Neuroscience 2005 6 5 351 362 2-s2.0-17844366846 10.1038/nrn1665 (Pubitemid 40593481)
203. Galceran J., Miyashita-Lin E. M., Devaney E., Rubenstein J. L. R., Grosschedl R., Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 2000 127 3 469 482 2-s2.0-0033950382 (Pubitemid 30093395)
204. Zhou C. J., Zhao C., Pleasure S. J., Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. Journal of Neuroscience 2004 24 1 121 126 2-s2.0-0842322748 10.1523/JNEUROSCI. 4071-03.2004 (Pubitemid 38181677)
205. Yu X., Malenka R. C., Beta-catenin is critical for dendritic morphogenesis. Nature Neuroscience 2003 6 1169 1177
206. Gao X., Arlotta P., Macklis J. D., Chen J., Conditional knock-out of β -catenin in postnatal-born dentate gyrus granule neurons results in dendritic malformation. Journal of Neuroscience 2007 27 52 14317 14325 2-s2.0-37549062258 10.1523/JNEUROSCI.3206-07.2007
207. Zaghetto A. A., Paina S., Mantero S., Platonova N., Peretto P., Bovetti S., Puche A., Piccolo S., Merlo G. R., Activation of the Wnt- β catenin pathway in a cell population on the surface of the forebrain is essential for the establishment of olfactory axon connections. Journal of Neuroscience 2007 27 36 9757 9768 2-s2.0-34547106495 10.1523/JNEUROSCI.0763-07.2007 (Pubitemid 47492180)
208. Purro S. A., Ciani L., Hoyos-Flight M., Stamatakou E., Siomou E., Salinas P. C., Wnt regulates axon behavior through changes in microtubule growth directionality: a new role for adenomatous polyposis coli. Journal of Neuroscience 2008 28 34 8644 8654 2-s2.0-51649085383 10.1523/JNEUROSCI.2320-08. 2008
209. Bamji S. X., Shimazu K., Kimes N., Huelsken J., Birchmeier W., Lu B., Reichardt L. F., Role of β -catenin in synaptic vesicle localization and presynaptic assembly. Neuron 2003 40 4 719 731 2-s2.0-0242573316 10.1016/S0896-6273(03)00718-9 (Pubitemid 37431033)
210. Hernández F., Borrell J., Guaza C., Avila J., Lucas J. J., Spatial learning deficit in transgenic mice that conditionally over-express GSK-3 β in the brain but do not form tau filaments. Journal of Neurochemistry 2002 83 6 1529 1533 2-s2.0-1642363745 10.1046/j.1471-4159.2002.01269.x (Pubitemid 35477491)
211. Yost C., Torres M., Miller J. R., Huang E., Kimelman D., Moon R. T., The axis-inducing activity, stability, and subcellular distribution of β -catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes and Development 1996 10 12 1443 1454 2-s2.0-0029683606 (Pubitemid 26260702)
212. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R., β -catenin is a target for the ubiquitin-proteasome pathway. EMBO Journal 1997 16 13 3797 3804 2-s2.0-0030978351 10.1093/emboj/16.13.3797 (Pubitemid 27280995)
213. Li L., Yuan H., Weaver C. D., Mao J., Farr G. H., Sussman D. J., Jonkers J., Kimelman D., Wu D., Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO Journal 1999 18 15 4233 4240 2-s2.0-0033517102 10.1093/emboj/18.15.4233 (Pubitemid 29364125)
214. Logan C. Y., Nusse R., The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004 20 781 810 2-s2.0-8444251784 10.1146/annurev.cellbio.20.010403.113126 (Pubitemid 39488658)
215. Jope R. S., Bijur G. N., Mood stabilizers, glycogen synthase kinase-3 β and cell survival. Molecular Psychiatry 2002 7 supplement 1 S35 S45 2-s2.0-0036214603 10.1038/sj/mp/4001017 (Pubitemid 34280647)
216. Hernández F., Nido J. D., Avila J., Villanueva N., GSK3 inhibitors and disease. Mini-Reviews in Medicinal Chemistry 2009 9 9 1024 1029 2-s2.0-70349562237 10.2174/138955709788922647
217. Klein P. S., Melton D. A., A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 1996 93 8455 8459 (Pubitemid 26269579)
218. Wada A., Yokoo H., Yanagita T., Kobayashi H., Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. Journal of Pharmacological Sciences 2005 99 4 307 321 2-s2.0-29144471908 10.1254/jphs.CRJ05009X (Pubitemid 41813422)
219. Eom T. Y., Jope R. S., Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation. Biological Psychiatry 2009 66 5 494 502 2-s2.0-68049121855 10.1016/j.biopsych.2009.04.015
220. Lie D. C., Colamarino S. A., Song H. J., Désiré L., Mira H., Consiglio A., Lein E. S., Jessberger S., Lansford H., Dearie A. R., Gage F. H., Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005 437 7063 1370 1375 2-s2.0-25844432119 10.1038/nature04108 (Pubitemid 41568684)
221. Wexler E. M., Andres P., Kornblum H. I., Palmer T. D., Geschwind D. H., Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells 2009 27 5 1130 1141 2-s2.0-70450218668 10.1002/stem.36
222. Adachi K., Mirzadeh Z., Sakaguchi M., Yamashita T., Nikolcheva T., Gotoh Y., Peltz G., Gong L., Kawase T., Alvarez-Buylla A., Okano H., Sawamoto K., β -catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 2007 25 11 2827 2836 2-s2.0-36248932103 10.1634/stemcells.2007-0177 (Pubitemid 350127867)
223. Uchida N., Honjo Y., Johnson K. R., Wheelock M. J., Takeichi M., The catenin/cadherin adhesion system is localized in synaptic junctions bordering transmitter release zones. Journal of Cell Biology 1996 135 3 767 779 2-s2.0-0029807018 10.1083/jcb.135.3.767 (Pubitemid 26372931)
224. Miskevich F., Zhu Y., Ranscht B., Sanes J. R., Expression of multiple cadherins and catenins in the chick optic tectum. Molecular and Cellular Neurosciences 1998 12 4-5 240 255 2-s2.0-0031786281 10.1006/mcne.1998.0718 (Pubitemid 28536077)
225. Yao I., Iida J., Tanaka N., Hata Y., Medical T., University D., Interaction of synaptic scaffolding molecule and β -catenin. Journal of Neuroscience 2002 22 3 757 765 2-s2.0-0036470661 (Pubitemid 34141756)
226. Nelson W. J., Nusse R., Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004 303 5663 1483 1487 2-s2.0-1542347695 10.1126/science. 1094291 (Pubitemid 38314410)
227. Togashi H., Abe K., Mizoguchi A., Takaoka K., Chisaka O., Takeichi M., Cadherin regulates dendritic spine morphogenesis. Neuron 2002 35 1 77 89 2-s2.0-0037014446 10.1016/S0896-6273(02)00748-1 (Pubitemid 34804324)
228. Shevtsov S. P., Haq S., Force T., Activation of β -catenin signaling pathways by classical G-protein-coupled receptors: mechanisms and consequences in cycling and non-cycling cells. Cell Cycle 2006 5 20 2295 2300 2-s2.0-33751242287 (Pubitemid 44785835)
229. Jin T., George Fantus I., Sun J., Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of β -catenin. Cellular Signalling 2008 20 10 1697 1704 2-s2.0-49549108896 10.1016/j.cellsig.2008.04.014
230. Kunz J., Henriquez R., Schneider U., Deuter-Reinhard M., Movva N. R., Hall M. N., Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 1993 73 3 585 596 2-s2.0-0027311858 10.1016/0092-8674(93)90144-F (Pubitemid 23143356)
231. Heitman J., Movva N. R., Hall M. N., Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991 253 5022 905 909 2-s2.0-0025776523 (Pubitemid 21917235)
232. Helliwell S. B., Wagner P., Kunz J., Deuter-Reinhard M., Henriquez R., Hall M. N., TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Molecular Biology of the Cell 1994 5 1 105 118 2-s2.0-0028137771
233. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J. L., Bonenfant D., Oppliger W., Jenoe P., Hall M. N., Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Molecular Cell 2002 10 3 457 468 2-s2.0-0036753494 10.1016/S1097-2765(02)00636-6 (Pubitemid 35284167)
234. Jacinto E., Loewith R., Schmidt A., Lin S., Rüegg M. A., Hall A., Hall M. N., Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biology 2004 6 11 1122 1128 2-s2.0-7944235758 10.1038/ncb1183 (Pubitemid 39468014)
235. Takahara T., Hara K., Yonezawa K., Sorimachi H., Maeda T., Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region. Journal of Biological Chemistry 2006 281 39 28605 28614 2-s2.0-33749406921 10.1074/jbc.M606087200 (Pubitemid 44507003)
236. Harwood F. C., Shu L., Houghton P. J., mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A. Journal of Biological Chemistry 2008 283 5 2575 2585 2-s2.0-41449089311 10.1074/jbc.M706173200
237. Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y., Iemura S. I., Natsume T., Takehana K., Yamada N., Guan J. L., Oshiro N., Mizushima N., Nutrient-dependent mTORCl association with the ULK1-Atg13-FIP200 complex required for autophagy. Molecular Biology of the Cell 2009 20 7 1981 1991 2-s2.0-65249119430 10.1091/mbc.E08-12-1248
238. Hoeffer C. A., Klann E., mTOR signaling: at the crossroads of plasticity, memory and disease. Trends in Neurosciences 2010 33 2 67 75 2-s2.0-75749114797 10.1016/j.tins.2009.11.003
239. Livingstone M., Atas E., Meller A., Sonenberg N., Mechanisms governing the control of mRNA translation. Physical Biology 2010 7 2 2-s2.0-77952393003 10.1088/1478-3975/7/2/021001 021001
240. Hay N., Sonenberg N., Upstream and downstream of mTOR. Genes and Development 2004 18 16 1926 1945 2-s2.0-4043171462 10.1101/gad.1212704 (Pubitemid 39071573)
241. Gong R., Chang S. P., Abbassi N. R., Tang S. J., Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. Journal of Biological Chemistry 2006 281 27 18802 18815 2-s2.0-33745924695 10.1074/jbc.M512524200 (Pubitemid 44043076)
242. Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N., Schuman E. M., A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 467 472 2-s2.0-0037039358 10.1073/pnas.012605299 (Pubitemid 34060384)
243. Duman R. S., Li N., Liu R. J., Duric V., Aghajanian G., Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012 62 35 41
244. Chong Z. Z., Shang Y. C., Zhang L., Wang S., Maiese K., Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxidative Medicine and Cellular Longevity 2010 3 6 374 391 2-s2.0-79951529849
245. An W. L., Cowburn R. F., Li L., Braak H., Alafuzoff I., Iqbal K., Iqbal I. G., Winblad B., Pei J. J., Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. American Journal of Pathology 2003 163 591 607 (Pubitemid 36909421)
246. Zhu W. L., Shi H. S., Wang S. J., Wu P., Ding Z. B., Lu L., Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats. Journal of Neurochemistry 2011 117 6 1075 1086 2-s2.0-79957986342 10.1111/j.1471-4159.2011.07285.x
247. Jernigan C. S., Goswami D. B., Austin M. C., Iyo A. H., Chandran A., Stockmeier C. A., Karolewicz B., The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 7 1774 1779 2-s2.0-79961129428 10.1016/j.pnpbp.2011.05.010
248. Cleary C., Linde J. A. S., Hiscock K. M., Hadas I., Belmaker R. H., Agam G., Flaisher-Grinberg S., Einat H., Antidepressive-like effects of rapamycin in animal models: implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Research Bulletin 2008 76 5 469 473 2-s2.0-44549087727 10.1016/j.brainresbull.2008.03.005
249. Yoon S. C., Seo M. S., Kim S. H., Jeon W. J., Ahn Y. M., Kang U. G., Kim Y. S., The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex. Neuroscience Letters 2008 434 1 23 28 2-s2.0-40649119181 10.1016/j.neulet.2008.01.020
250. Maeng S., Zarate C. A. Jr., Du J., Schloesser R. J., McCammon J., Chen G., Manji H. K., Cellular mechanisms underlying the antidepressant effects of
251. Koike H., Iijima M., Chaki S., Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuropharmacology 2011 61 1419 1423
252. Yang C., Hu Y. M., Zhou Z. Q., Zhang G. F., Yang J. J., Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Upsala Journal of Medical Sciences 2013 118 1 3 8 10.3109/03009734.2012.724118
253. Zarate C. A. Jr., Singh J. B., Carlson P. J., Brutsche N. E., Ameli R., Luckenbaugh D. A., Charney D. S., Manji H. K., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 2006 63 8 856 864 2-s2.0-33746896935 10.1001/archpsyc.63.8.856 (Pubitemid 44188478)
254. Elfving B., Wegener G., Electroconvulsive seizures stimulate the vegf pathway via mTORC1. Synapse 2012 66 340 345
255. Dwyer J. M., Lepack A. E., Duman R. S., mTOR activation is required for the antidepressant effects of mGluR(2)/(3) blockade. International Journal of Neuropsychopharmacology 2012 15 429 434
256. Eisch A. J., Adult neurogenesis: implications for psychiatry. Progress in Brain Research 2002 138 315 342 2-s2.0-0036454284 10.1016/S0079-6123(02)38085-3 (Pubitemid 35460921)
257. Li Y., Luikart B. W., Birnbaum S., Chen J., Kwon C. H., Kernie S. G., Bassel-Duby R., Parada L. F., TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008 59 3 399 412 2-s2.0-48749115329 10.1016/j.neuron.2008.06.023
258. Pittenger C., Duman R. S., Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008 33 1 88 109 2-s2.0-36549030795 10.1038/sj.npp.1301574 (Pubitemid 350191319)
259. Fuchs E., Czéh B., Kole M. H. P., Michaelis T., Lucassen P. J., Alterations of neuroplasticity in depression: the hippocampus and beyond. European Neuropsychopharmacology 2004 14 supplement 5 S481 S490 2-s2.0-8844227506 10.1016/j.euroneuro.2004.09.002 (Pubitemid 39531609)
260. Watanabe Y., Gould E., McEwen B. S., Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Research 1992 588 2 341 345 2-s2.0-0026781307 10.1016/0006-8993(92)91597-8
261. Norrholm S. D., Ouimet C. C., Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 2001 42 3 151 163 2-s2.0-0035889727 10.1002/syn.10006 (Pubitemid 32999622)
262. Nakagawa S., Kim J. E., Lee R., Malberg J. E., Chen J., Steffen C., Zhang Y. J., Nestler E. J., Duman R. S., Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. Journal of Neuroscience 2002 22 9 3673 3682 2-s2.0-0036581252 (Pubitemid 37465772)
263. Christoffel D. J., Golden S. A., Russo S. J., Structural and synaptic plasticity in stress-related disorders. Annual Review of Neuroscience 2011 22 535 549
264. Lamont S. R., Stanwell B. J., Hill R., Reid I. C., Stewart C. A., Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus. Brain Research 2005 1053 1-2 27 32 2-s2.0-23644433159 10.1016/j.brainres.2005.06.041 (Pubitemid 41116787)